article thumbnail

3 Count: Pokemon with Litigation

Plagiarism Today

The post 3 Count: Pokemon with Litigation appeared first on Plagiarism Today. Nintendo sues Palworld developer, judge trims Office Depot's legal fees and Amazon joints the Motion Picture Association.

article thumbnail

3 Count: A Decade of Litigation

Plagiarism Today

The post 3 Count: A Decade of Litigation appeared first on Plagiarism Today. Oracle wins more attorney fees in Rimini case, OpenAI to allow access to training data and Telegram removes Z-Library posts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Count: Mechanical Litigation

Plagiarism Today

The post 3 Count: Mechanical Litigation appeared first on Plagiarism Today. Spotify sued by Mechanical Licensing Collective, Internet Archive fails to get music lawsuit tossed and Sony Music opts out of AI training.

article thumbnail

AI Litigation Update

Creative Law Center

This post, an AI litigation update, is a snapshot in time looking at what is going on in two of the active cases. The post AI Litigation Update appeared first on Creative Law Center. Legal challenges to generative AI are on the rise.

article thumbnail

3 Count: Humans of Litigation

Plagiarism Today

The post 3 Count: Humans of Litigation appeared first on Plagiarism Today. Humans of New York creator unhappy with Bombay counterpart, Danish man faces prison over hacked streaming accounts and more.

article thumbnail

Spotlight On: Biosimilar Litigations - August 2024

JD Supra Law

Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors as well as litigations between two biosimilar applicants/manufacturers are included. By: Venable LLP

article thumbnail

Spotlight On: Biosimilar Litigations - October 2024

JD Supra Law

Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors as well as litigations between two biosimilar applicants/manufacturers are included. By: Venable LLP